)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Kairos Pharma
Kairos Pharma (KAPA) investor relations material
Kairos Pharma AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary29 Jun, 2026
Opening remarks and agenda
Meeting called to order by CEO and Chairman John Yu, with executive officers introduced and agenda distributed to attendees.
Matters to be voted on included director elections, auditor ratification, reverse stock split, executive compensation, and equity plan amendments.
Shareholder proposals
Proposals included election of four directors, ratification of auditors, approval of a reverse stock split, advisory approval of executive compensation, and amendments to the equity incentive plan.
Motions to approve all proposals were made and seconded by stockholders Neil Bhowmick and Ramachandran Murali.
Overview of voting outcomes
All director nominees were elected to the board.
Auditor ratification, reverse stock split amendment, executive compensation, and equity incentive plan amendments (including a 5 million share increase and 10-year evergreen provision) were all approved.
Final voting results will be reported in a Form 8-K filing with the SEC within four business days.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Kairos Pharma
- Lead antibody ENV105 targets drug resistance in cancer, with key trial readouts expected soon.KAPA
Maxim Group’s 2024 Healthcare Virtual Summit8 Jul 2026 - 2026 Annual Meeting set for June 29 with voting rights for shareholders as of May 18, 2026.KAPAProxy filing26 May 2026
- Virtual meeting to vote on directors, auditor, reverse split, and expanded equity plan.KAPAProxy filing22 May 2026
- Advancing drug resistance therapies with major 2026 clinical and partnership milestones ahead.KAPA16th Annual LD Micro Invitational Conference18 May 2026
- ENV105 and KROS 741 advance in trials to address cancer resistance, backed by strong funding.KAPAInvestor presentation18 May 2026
- Q1 2026 net loss widened to $1.65M, cash at $3.68M, with new financing and manufacturing deals.KAPAQ1 202613 May 2026
- Stockholders will vote on director elections, a reverse split, auditor ratification, and equity plan changes.KAPAProxy filing11 May 2026
- Net loss rose to $5.4M in 2025; cash of $4.5M may not fund operations for 12 months.KAPAQ4 202531 Mar 2026
- Novel antibody therapies aim to overcome cancer drug resistance, with key data expected in 2025.KAPA17th Annual LD Micro Main Event Conference17 Jan 2026
Next Kairos Pharma earnings date
Q2 202612 Aug, 2026
Kairos Pharma
Next Kairos Pharma earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage